Mon, May 12, 11:33 AM (32 days ago)
**Wellgistics Health, Inc. (WGRX) Q1 2025 Financial Summary** **Financial Health & Performance:** - **Revenue:** $10.86 million, derived from pharmacy operations post-acquisitions. - **Gross Profit:** $692,641, with a 6.4% margin. - **Net Loss:** $32.43 million, primarily due to high operating expenses. - **Operating Expenses:** $32.04 million, including $27.77 million in stock-based compensation. - **Cash Flow:** Negative $1.35 million from operations, offset by $3.11 million from financing activities. **Key Metrics:** - **Cash & Equivalents:** $2.52 million. - **Total Assets:** $58.06 million. - **Total Liabilities:** $53.58 million. - **Stockholders' Equity:** $4.48 million. **Trends & Uncertainties:** - **Revenue Growth:** Expected from pharmacy and wholesale operations. - **Expenses:** High stock-based compensation and amortization of intangibles. - **Liquidity:** Dependent on financing activities and potential additional capital raises. - **Uncertainties:** Market conditions, regulatory changes, and competition. **Future Operations:** - **Strategic Initiatives:** Expanding pharmacy services, enhancing technology platform, and growing wholesale operations. - **Financing:** Plans to raise additional capital as needed. - **Risk Factors:** Liquidity needs, market adoption, and competitive pressures. **Management's Outlook:** - **Revenue Growth:** Anticipated from expanded services and market penetration. - **Cost Management:** Focus on optimizing expenses and improving operational efficiency. - **Strategic Acquisitions:** Potential for further acquisitions to enhance market position. **Conclusion:** Wellgistics Health, Inc. is in a growth phase, with significant investments in acquisitions and technology. The company faces challenges in managing high operating expenses and ensuring liquidity. However, it has a strategic plan to expand services, improve operational efficiency, and raise additional capital to support future growth.